Intellia Therapeutics CEO John Leonard has, for the last couple years, found himself stuck in a financial Groundhog Day.

With a bunch of gene therapy and gene editing programs in clinical trials, CRISPR Therapeutics (NASDAQ: CRSP) has an ...

A new study presents "Evo" – a machine learning model capable of decoding and designing DNA, RNA, and protein sequences, from molecular to genome scale, with unparalleled accuracy. Evo's ability to ...

Genetic studies have revealed that when male mosquitoes lose their hearing, they also lose their sex lives. The surprising ...

Study links prenatal THC exposure to increased opioid addiction risk in later life, raising concerns for cannabis use during ...

Selenoproteins are crucial for several biological functions, including the breakdown of harmful substances, immune system ...

BEIJING, Nov. 16 (China Economic Net) - From November 14 to 15, the 11th Cell Biology Industry Conference (CBIC) opened in ...

Advancing four clinical-stage programs for hematologic malignancies and autoimmune diseases; multiple clinical data reports planned for 2025 -- -- Enrolling patients with LBCL (2L and after prior CD19 ...

Is the future of finance already written in the DNA of today's emerging technologies? Cathie Wood, CEO and CIO of Ark Invest, ...

RNA viruses pose significant challenges to public health due to their high mutation rates and diverse mechanisms of infection which allow them to rapidly adapt to new hosts and evade therapeutic ...

From the first approved CRISPR treatment to AI designing its own computer chips, check out this week's awesome tech stories ...